Randomized Trial on Acutely Dissected Aorta Repair With Hemiarch Replacement With or Without Stent Implantation (RADAR Trial)
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 72
- 试验地点
- 2
- 主要终点
- Incidence of DANE
研究概览
简要总结
Acute DeBakey type I aortic dissection (ATAD) is one of the most lethal surgical emergencies. The conventional operative strategy is hemiarch replacement under cardiopulmonary bypass support to replace the diseased segment of the ascending aorta. However, in patients with dissection involving the whole aortic arch and descending thoracic aorta, the presence of the persistently perfused false lumen can lead to late aneurysm formation and require a second-stage operation, and this reduces long-term survival. In the surgical literature, there is growing evidence that the presence of Distal Anastomosis New Entry (DANE), which is a new intimal defect related to the trauma created by surgical sutures, is associated with persistent perfusion of the false lumen, aortic size growth, and the need of re-operation. The Ascyrus Medical Dissection Stent (AMDS; Artivion, Atlanta, Georgia, USA) is a hybrid prosthesis with a proximal sewing collar and distal nitinol self-expanding un-covered stent system designed to reduce the occurrence of DANE and hopefully depressurize the false lumen and lead to remodeling of the aortic wall.
The investigators plan to prospectively recruit consecutive patients with acute ascending thoracic aortic dissection patients (Excluding DeBakey II) and randomized them, after informed consent, into either the conventional hemiarch replacement group (Hemiarch-C) or the hemiarch replacement plus AMDS implantation group (Hemiarch-AMDS). The participating team will collect pre-operative, intra-operative and post-operative clinical and radiological parameters for two groups of patients. Written informed consent, specifically allowing the use of clinical records for this randomized study, will be obtained from every patient prior to data collection. Complete DICOM image files of the CT scans will be evaluated by two independent fully qualified Radiologists. Our primary outcome is the radiological detection of DANE in Hemiarch-C and Hemiarch-AMDS groups within the 12-month follow-up period.
This study will be the world's first randomized control trial in ATAD to compare the prevalence of DANE in Hemiarch-C and Hemiarch-AMDS. It could be a guideline-changing study for the treatment of ATAD and its impact on the immediate survival, second-stage treatment, and long-term survival of patients suffering from ATAD.
详细描述
Project Objectives
- To compare the occurrence of Distal Anastomosis New Entry (DANE) after conventional hemiarch replacement group (Hemiarch-C) and the hemiarch replacement plus AMDS implantation group (Hemiarch-AMDS).
- To compare the rate of all-cause mortality and aortic related mortality (at 30 days, 3-6, 12 months follow-up) between the study groups
- To compare the rate of patients who are free from the following Major Adverse Events (MAEs) (new permanent disabling stroke, new permanent (> 30 days) paraplegia or paraparesis, reintervention, all-cause mortality) (at 12 months follow-up)
- To compare radiological outcomes in terms of the rate of stenosis in supra-aortic head vessels, increasing (≥ 5 mm), stable or decreasing (≥ 5 mm) in true lumen in in both groups (at 3-6, 12 months follow-up).
- To compare the radiological outcomes in terms of obliterated, completely thrombosed, partially thrombosed, or patent false lumen at various segments of aorta in both groups (at 3-6, 12 months follow-up).Thoracic aortic aneurysms (TAAs) and their complications (i.e. dissection, rupture, etc.) cause more than 1400 hospital admissions and 300 deaths every year in Hong Kong. Acute aortic dissection involving the ascending thoracic aorta is a highly lethal surgical emergency that warrants immediate surgical intervention. It can be classified according to DeBakey classification (DeBakey Type I, II, or III). The ascending thoracic aorta is involved in DeBakey Type I and II aortic dissections. In DeBakey Type I (ATAD), the aortic arch and descending thoracic aorta are also involved in the dissection process, therefore conventional hemiarch replacement is only considered "palliative".
Data from international registries showed the mortality of surgically treated ATAD was around 17-26% and those with mal-perfusion had even higher mortality. A significant number of patients of ATAD after conventional hemiarch replacement still have a persistent pressurized false lumen and this is related to the presence of distal anastomotic new entry (DANE).The presence of DANE leads to persistent pulsatile flow and pressurization of the false lumen in 70% of cases after hemiarch replacement.The persistently patent FL will in turn cause mal-perfusion, the need for aortic re-intervention involving the aortic arch, and, most importantly, reduced long-term survival by up to 50%.
To avoid the occurrence of DANE and downstream aortic mal-perfusion, Bozso and colleagues advocated the use of a novel Ascyrus Medical Dissection Stent (AMDS; Artivion, Atlanta, Georgia, US) hybrid prosthesis which comprises a proximal sewing collar and a distal self-expanding nitinol un-covered stent. From a prospective trial utilizing AMDS in ATAD, the Dissected Aorta Repair Through Stent Implantation (DARTS) trial, by Boszo and colleagues, the positive remodeling of the aortic arch occurred in 100% of cases with complete obliteration or thrombosis of the false lumen in 74%. In their series of 47 patients, there was no DANE after the AMDS implantation.
Work done by the principal investigator's unit is a major referral center for acute and complex aortic disease in Hong Kong, with more than 100 cases of operated aortic cases and 200 aortic referrals each year. The investigator's unit also operated on an average of 40-50 cases of ATAD each year.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient´s age is between 18 and 80 years.
- •Patient is willing and able to give informed consent.
- •Patient has acute DeBakey Type I and requires repair or replacement of damaged or diseased vessels of the ascending aorta.
- •Patient not in coma/irreversible end organ failure/cardiac massage for resuscitation, at the time of consent.
排除标准
- •Patient has aortic arch diameter of more than 4.5 cm
- •Patient has known connective tissue disease or genetically linked aortopathy
- •Patient has entry tear more than 2 cm over aortic arch
- •Patient with DeBakey Type II aortic dissection
- •Patient has co-morbidity (i.e. active malignancy (progressive, stable or partial remission)) causing expected survival to be less than 2 years.
- •Patient has any other medical, social, or psychological problems, that in the opinion of the investigator, preclude the patient from participating in this study.
结局指标
主要结局
Incidence of DANE
时间窗: At Discharge(0-14days), 30-day, 3-6 month, 12 month
The presence of Distal Anastomosis New Entry (DANE) diagnosed by Computed Tomography in post-operative imaging within the 12-month follow-up period
次要结局
- All-cause mortality of the patients(At discharge(0-14days), 30-day, 3-6 month, 12 month)
- Percentage of patient with aortic-related mortality(At Discharge(0-14days), 30-day, 3-6 month, 12 month)
- Percentage of patients with Major Adverse Events(At Discharge(0-14days), 30-day, 3-6 month, 12 month)
- Percentage of patients with radiological head and neck vessels patency(At Discharge(0-14days), 30-day, 3-6 month, 12 month)
- Percentage of patient with failure of AMDS(At Discharge(0-14days), 30-day, 3-6 month, 12 month)
- Percentage of patients with radiological true and false lumen status of the aortic arch and descending thoracic aorta(At Discharge(0-14days), 30-day, 3-6 month, 12 month)
- Percentage of patients with Renal failure(At Discharge(0-14days), 30-day, 3-6 month, 12 month)
- Percentage of patients requiring additional aortic intervention(At Discharge(0-14days), 30-day, 3-6 month, 12 month)
研究者
Randolph Wong
Professor and Chief of Division of Cardiothoracic Surgery, Department of Surgery
Chinese University of Hong Kong
